Moi Davide, Carradori Simone, Gallorini Marialucia, Mencarelli Noemi, Deplano Alberto, Angeli Andrea, Vittorio Serena, Supuran Claudiu T, Onnis Valentina
Department of Life and Environmental Sciences, Unit of Pharmaceuitical, Pharmacological and Nutraceutical Sciences, University of Cagliari, Cittadella Universitaria di Monserrato, I-09042 Monserrato, CA, Italy.
Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, Via dei Vestini 31, I-66100 Chieti, CH, Italy.
Pharmaceuticals (Basel). 2025 Mar 5;18(3):372. doi: 10.3390/ph18030372.
-Aggressive solid tumors are commonly characterized by both basic intracellular pH and acidic extracellular pH, which increase cell survival and proliferation. As carbonic anhydrases IX/XII are involved in this pH regulation, their inhibition is an appealing approach in cancer therapy, avoiding cancer cell survival and proliferation. Substituted coumarins are selective non-classical CA IX and CA XII inhibitors. -In this study, new 7-hydroxycoumarinamides were synthesized and assayed for CA inhibition and antiproliferative activity. -All of the coumarinamides showed human CA IX and CA XII selective inhibition over the off-target CA I and CA II isoforms. Coumarin acts as a suicide inhibitor because its heterocyclic ring can be hydrolyzed by CA esterase activity to give the corresponding 2-hydroxycinnamic acid derivative which blocks the entrance of the active site. The 2-hydroxycinnamic acid derivatives deriving from the most potent and selective coumarinamides were docked into CA IX and XII to better understand the activity and selectivity against the two CA isoforms. The most active coumarinamides also produced a decrease of A549 cell proliferation and were able to arrest cells at the G1/S checkpoint. -These results may open new perspectives for developing coumarin-based CA IX/XII inhibitors.
侵袭性实体瘤通常具有细胞内碱性pH值和细胞外酸性pH值的特征,这会增加细胞的存活和增殖。由于碳酸酐酶IX/XII参与这种pH调节,抑制它们是癌症治疗中一种有吸引力的方法,可避免癌细胞的存活和增殖。取代香豆素是选择性非经典CA IX和CA XII抑制剂。
在本研究中,合成了新型7-羟基香豆素酰胺,并检测了其对碳酸酐酶的抑制作用和抗增殖活性。
所有香豆素酰胺对脱靶的CA I和CA II同工型均表现出对人CA IX和CA XII的选择性抑制。香豆素作为一种自杀性抑制剂,因为其杂环可被CA酯酶活性水解,生成相应的2-羟基肉桂酸衍生物,该衍生物会阻断活性位点的入口。将源自最有效和选择性最强的香豆素酰胺的2-羟基肉桂酸衍生物对接至CA IX和XII中,以更好地了解其对这两种CA同工型的活性和选择性。活性最强的香豆素酰胺还能降低A549细胞的增殖,并能够使细胞停滞在G1/S检查点。
这些结果可能为开发基于香豆素的CA IX/XII抑制剂开辟新的前景。